Researchers are asking for participants who are at high risk for being exposed to COVID-19. The first study is expected to launch in August, and it will explore a potential vaccine for COVID-19. Earlier phases of the same study showed the drug safely increased antibody responses, according to the release. Antibodies are proteins that fight viruses and bacteria in the body.
Northwestern seeks 5,000 volunteers to participate in COVID-19 vaccine trials
Prepare Now Before its too Late
Discover where products are available & compare prices
